“CONCLUSION The use of an ioxidant substances de creases the cytotoxic effect of zol edronic acid ov er non-tumour cells, and as such could be used in benign diseases.”
“The administration of antioxidants together with the zoledronic acid shows a protective effect for normal prostate cells, yet not so for prostate tumour cells.”